3-amino-2-benzoyl-4-phenyl-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-b]pyridin-6-one

ID: ALA5201582

Chembl Id: CHEMBL5201582

PubChem CID: 168291401

Max Phase: Preclinical

Molecular Formula: C19H16N4O2

Molecular Weight: 332.36

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1c2c(nn1C(=O)c1ccccc1)NC(=O)CC2c1ccccc1

Standard InChI:  InChI=1S/C19H16N4O2/c20-17-16-14(12-7-3-1-4-8-12)11-15(24)21-18(16)22-23(17)19(25)13-9-5-2-6-10-13/h1-10,14H,11,20H2,(H,21,22,24)

Standard InChI Key:  NUDNOXLBFKAHNS-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5201582

    ---

Associated Targets(Human)

MKNK2 Tchem MAP kinase-interacting serine/threonine-protein kinase 1/2 (155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 332.36Molecular Weight (Monoisotopic): 332.1273AlogP: 2.63#Rotatable Bonds: 2
Polar Surface Area: 90.01Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.14CX Basic pKa: CX LogP: 2.92CX LogD: 2.92
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.75Np Likeness Score: -0.69

References

1. Bou-Petit E, Hümmer S, Alarcon H, Slobodnyuk K, Cano-Galietero M, Fuentes P, Guijarro PJ, Muñoz MJ, Suarez-Cabrera L, Santamaria A, Estrada-Tejedor R, Borrell JI, Ramón Y Cajal S..  (2022)  Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.,  65  (8.0): [PMID:35417652] [10.1021/acs.jmedchem.1c01941]

Source